# Pharmacodynamic Effects of Sibutramine on Gastric Function in Obesity

> **NCT00330525** · PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 72 (actual)

## Conditions studied

- Obesity
- Overweight

## Interventions

- **DRUG:** sibutramine

## Key facts

- **NCT ID:** NCT00330525
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2006-03
- **Final completion:** 2006-03
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2010-01-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00330525

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00330525, "Pharmacodynamic Effects of Sibutramine on Gastric Function in Obesity". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00330525. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*